Purchases and Sales Made in Q3 2023 in Xtl Biopharmaceuticals LTD (XTLB)
This table provides information about the institutional ownership of Xtl Biopharmaceuticals LTD (XTLB) during Q3 2023. The information is specifically focused on institutions that hold shares of XTL BIOPHARMACEUTICALS LTD.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
BUY
|
- |
120New |
$92.4 - $126
|
120
$193
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-600- 1.46% |
$462 - $630
|
40.6K
$65.3K
|